Data Science in the News

Data Days brings DOE labs together for discussions on data management and more

Data researchers, developers, data managers, and program managers from the DOE national laboratories visited LLNL on October 24–26 to discuss the latest in data management, sharing, and accessibility at the 2023 DOE Data Days (D3) workshop. Sponsored by the National Nuclear Security Administration’s (NNSA) Office of Defense Nuclear Nonproliferation and hosted annually by LLNL, the event...

ESGF launches effort to upgrade climate projection data system

The Earth System Grid Federation (ESGF), a multi-agency initiative that gathers and distributes data for top-tier projections of the Earth’s climate, is preparing a series of upgrades that will make using the data easier and faster while improving how the information is curated. The federation, led by the Department of Energy’s Oak Ridge National Laboratory in collaboration with Argonne and...

LLNL to cooperate with University of Utah's one oneAPI Center of Excellence

The University of Utah has announced the creation of a new oneAPI Center of Excellence focused on developing portable, scalable and performant data compression techniques. The oneAPI Center will be headed out of the University of Utah’s Center for Extreme Data Management Analysis and Visualization (CEDMAV) and will involve the cooperation of LLNL’s Center for Applied Scientific Computing. It...

An open-source, data-science toolkit for energy: GridDS

As the number of smart meters and the demand for energy is expected to increase by 50% by 2050, so will the amount of data those smart meters produce. While energy standards have enabled large-scale data collection and storage, maximizing this data to mitigate costs and consumer demand has been an ongoing focus of energy research. An LLNL team has developed GridDS—an open-source, data-science...

Panel discussion spotlights COVID-19 R&D

The DSI’s career panel series continued on June 28 to highlight some of LLNL’s COVID-19 research projects. Three data scientists—Emilia Grzesiak, Derek Jones, and Priyadip Ray—joined moderator and data scientist Stewart He to talk about their work in drug screening, protein–drug compounds, antibody–antigen sequence analysis, and risk factor identification. He, who earned a PhD in Computer...

UC Merced students work with LLNL mentors on potential new drugs to combat COVID-19

Students from the University of California, Merced worked with mentors at LLNL to identify drug compounds that could be used to treat COVID-19 during a two-week Data Science Challenge (DSC) that concluded on June 6. For the first time in the DSC series since the COVID-19 pandemic began in 2020, Lab mentors visited the college campus to provide in-person guidance for five teams of UC Merced...

LLNL’s Brase discusses advances by ATOM in accelerating drug discovery pipeline

The private-public Accelerating Therapeutic Opportunities in Medicine (ATOM) consortium is showing “significant” progress in demonstrating that HPC and M) tools can speed up the drug discovery process, said Jim Brase, ATOM co-lead and LLNL’s deputy associate director for data science. The consortium currently boasts more than a dozen member organizations, including national laboratories...

Kevin McLoughlin applies computational biology to complex problems

Kevin McLoughlin has always been fascinated by the intersection of computing and biology. His LLNL career encompasses award-winning microbial detection technology, a COVID-19 antiviral drug design pipeline, and work with the ATOM consortium. The appeal for him in these projects lies at the intersection of computing and biology. “I love finding ways to visualize data that reveal relationships...

Machine learning model finds COVID-19 risks for cancer patients

A new study by researchers at LLNL and the University of California, San Francisco, looks to identify cancer-related risks for poor outcomes from COVID-19. Analyzing one of the largest databases of patients with cancer and COVID-19, the team found previously unreported links between a rare type of cancer—as well as two cancer treatment-related drugs—and an increased risk of hospitalization...

LLNL team models COVID-19 disease progression and identifies risk factors

An LLNL team has developed a comprehensive dynamic model of COVID-19 disease progression in hospitalized patients, finding that risk factors for complications from the disease are dependent on the patient’s disease state. Using a machine learning algorithm on a dataset of electronic health records from more than 1,300 hospitalized COVID-19 patients with ProMedica — the largest health care...

LLNL joins Human Vaccines Project to accelerate vaccine development and understanding of immune response

LLNL has joined the international Human Vaccines Project (HVP), bringing Lab expertise and computing resources to the consortium to aid development of a universal coronavirus vaccine and improve understanding of immune response. The HVP is a nonprofit, public-private partnership with a mission to decode the human immune system and accelerate the development of vaccines and immunotherapies...

Tackling the COVID-19 pandemic

To help the U.S. fight the COVID-19 pandemic, LLNL did what it does best: quickly bring together interdisciplinary teams and diverse technologies to address urgent national challenges. This effort includes applying advanced high-performance computing resources to biological research and anayzing complicated computer models and enormous datasets. Read more in Science & Technology Review.

Inaugural industry forum inspires ML community

LLNL held its first-ever Machine Learning for Industry Forum (ML4I) on August 10–12. Co-hosted by the Lab’s High-Performance Computing Innovation Center (HPCIC) and Data Science Institute (DSI), the virtual event brought together more than 500 enrollees from the Department of Energy (DOE) complex, commercial companies, professional societies, and academia. Industry sponsors included...

COVID-19 detection and analysis with Nisha Mulakken (VIDEO)

LLNL biostatistician Nisha Mulakken has enhanced the Lawrence Livermore Microbial Detection Array (LLMDA) system with detection capability for all variants of SARS-CoV-2. The technology detects a broad range of organisms—viruses, bacteria, archaea, protozoa, and fungi—and has demonstrated novel species identification for human health, animal health, biodefense, and environmental sampling...

Conference papers highlight importance of data security to machine learning

The 2021 Conference on Computer Vision and Pattern Recognition, the premier conference of its kind, will feature two papers co-authored by an LLNL researcher targeted at improving the understanding of robust machine learning models. Both papers include contributions from LLNL computer scientist Bhavya Kailkhura and examine the importance of data in building models, part of a Lab effort to...

COVID-19 HPC Consortium reflects on past year

COVID-19 HPC Consortium scientists and stakeholders met virtually on March 23 to mark the consortium’s one-year anniversary, discussing the progress of research projects and the need to pursue a broader organization to mobilize supercomputing access for future crises. The White House announced the launch of the public-private consortium, which provides COVID-19 researchers with free access to...

Winter hackathon highlights data science talks and tutorial

The Data Science Institute (DSI) sponsored LLNL’s 27th hackathon on February 11–12. Held four times a year, these seasonal events bring the computing community together for a 24-hour period where anything goes: Participants can focus on special projects, learn new programming languages, develop skills, dig into challenging tasks, and more. The winter hackathon was the DSI’s second such...

Lawrence Livermore computer scientist heads award-winning computer vision research

The 2021 IEEE Winter Conference on Applications of Computer Vision (WACV 2021) on Wednesday announced that a paper co-authored by LLNL computer scientist Rushil Anirudh received the conference’s Best Paper Honorable Mention award based on its potential impact to the field. The paper, titled "Generative Patch Priors for Practical Compressive Image Recovery,” introduces a new kind of prior—a...

Model for COVID-19 drug discovery a Gordon Bell finalist

A machine learning model developed by a team of LLNL scientists to aid in COVID-19 drug discovery efforts is a finalist for the Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research. Using Sierra, the world’s third fastest supercomputer, LLNL scientists produced a more accurate and efficient generative model to enable COVID-19 researchers to produce novel compounds...

Advancing healthcare with data science (VIDEO)

This video provides an overview of projects in which data scientists work with domain scientists to address major challenges in healthcare. To help fight the COVID-19 pandemic, researchers are developing computer models to search for potential antibody and antiviral drug treatments, sharing a data portal with scientists and the general public, and analyzing drug compounds via a novel text...